Related Experiment Video
Updated: Aug 13, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation
Jacques Demongeot1, Cécile Fougère1
1AGEIS & Telecom4Health, Faculty of Medicine, University Grenoble Alpes, 38700 La Tronche, France.
Background:
The adventure of the mRNA vaccine began thirty years ago in the context of influenza. This consisted in encapsulating the mRNA coding for a viral protein in a lipid particle. We show how the mRNA encoding S protein has been modified for that purpose in the context of the anti-SARS-CoV-2 vaccination.
Results:
by using data coming from genetic and epidemiologic databases, we show the theoretical possibility of fragmentation of this mRNA into small RNA sequences capable of inhibiting important bio-syntheses such as the production of beta-globin.
Discussion:
we discuss two aspects related to mRNA vaccine: (i) the plausibility of mRNA fragmentation, and (ii) the role of liposomal nanoparticles (LNPs) used in the vaccine and their impact on mRNA biodistribution.
Conclusion:
we insist on the need to develop lipid nanoparticles allowing personalized administration of vaccines and avoiding adverse effects due to mRNA fragmentation and inefficient biodistribution. Hence, we recommend (i) adapting the mRNA of vaccines to the least mutated virus proteins and (ii) personalizing its administration to the categories of chronic patients at risk most likely to suffer from adverse effects.
Insights
Messenger RNA (mRNA) vaccines, initially developed for influenza, have been adapted for SARS-CoV-2. Research suggests potential mRNA fragmentation and biodistribution issues with lipid nanoparticles (LNPs), necessitating personalized vaccine strategies.
Area of Science:
- Vaccinology
- Molecular Biology
- Virology
Background:
- Messenger RNA (mRNA) vaccine technology originated from influenza research approximately 30 years ago.
- Early mRNA vaccines involved encapsulating mRNA encoding viral proteins within lipid particles.
- Current mRNA vaccines for SARS-CoV-2 utilize modified mRNA encoding the S protein.
Purpose of the Study:
- To investigate the modifications of mRNA encoding the S protein for anti-SARS-CoV-2 vaccination.
- To assess the theoretical possibility of mRNA fragmentation and its potential impact on cellular biosynthesis.
- To analyze the role of liposomal nanoparticles (LNPs) in mRNA vaccine biodistribution and potential adverse effects.
Main Methods:
- Analysis of genetic and epidemiologic databases.
- Theoretical modeling of mRNA fragmentation and its biological consequences.
- Evaluation of LNP characteristics and their influence on mRNA biodistribution.
Main Results:
- Demonstrated the theoretical possibility of mRNA fragmentation into small RNA sequences.
- Identified potential inhibition of essential biosynthetic pathways, such as beta-globin production, due to fragmented mRNA.
- Highlighted concerns regarding mRNA biodistribution influenced by LNPs.
Conclusions:
- Discussed the plausibility of mRNA fragmentation in vaccines.
- Emphasized the need for improved LNPs for personalized vaccine administration to mitigate adverse effects.
- Recommended adapting vaccine mRNA to less mutated viral proteins and tailoring administration for at-risk patient groups.
More Related Videos
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Vaccinations
Microorganisms in Medicine and Therapeutics
Leaky Scanning
Viral Structure